fda semaglutide shortage resolved february 2025 announcement over An update from hims/hers: Compounded semaglutide prescriptions through them are not affected by the semaglutide shortage ISPOR 2025: Exploring reasons for – fda declares semaglutide shortage resolved

Some can stop using them altogether. Indeed, while the weight loss benefits of GLP-1 receptor agonists remain central to their effectiveness against sleep apnea, researchers are increasingly finding that their positive impact on sleep may run deeper

Constipation and bloating: Slowed gut motility can lead to less frequent bowel movements and persistent feelings of fullness or bloating

Observational studies In our systematic review, we included 17 observational studies involving 1592 participants who received GLP-1RAs after bariatric surgery

Pharmaceutical competition is intensifying

In addition to medications and labs, the monthly cost of the plan includes unlimited provider visits and ongoing support